Annual Long Term Debt
$45.68 M
+$39.72 M+666.22%
31 December 2023
Summary:
Inozyme Pharma annual long term debt is currently $45.68 million, with the most recent change of +$39.72 million (+666.22%) on 31 December 2023. During the last 3 years, it has risen by +$44.40 million (+3449.49%). INZY annual long term debt is now at all-time high.INZY Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$42.23 M
-$3.52 M-7.70%
30 September 2024
Summary:
Inozyme Pharma quarterly long term debt is currently $42.23 million, with the most recent change of -$3.52 million (-7.70%) on 30 September 2024. Over the past year, it has increased by +$9.02 million (+27.14%). INZY quarterly long term debt is now -7.70% below its all-time high of $45.75 million, reached on 30 June 2024.INZY Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INZY Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +666.2% | +27.1% |
| 3 y3 years | +3449.5% | +1392.7% |
| 5 y5 years | - | - |
INZY Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +3449.5% | -7.7% | +1785.2% |
| 5 y | 5 years | at high | +3449.5% | -7.7% | +3181.2% |
| alltime | all time | at high | +3449.5% | -7.7% | +3181.2% |
Inozyme Pharma Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $42.23 M(-7.7%) |
| June 2024 | - | $45.75 M(+0.1%) |
| Mar 2024 | - | $45.70 M(+0.0%) |
| Dec 2023 | $45.68 M(+666.2%) | $45.68 M(+37.5%) |
| Sept 2023 | - | $33.21 M(-0.1%) |
| June 2023 | - | $33.26 M(+28.8%) |
| Mar 2023 | - | $25.82 M(+333.1%) |
| Dec 2022 | $5.96 M | $5.96 M(-2.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $6.11 M(+172.7%) |
| June 2022 | - | $2.24 M(-8.3%) |
| Mar 2022 | - | $2.44 M(-7.5%) |
| Dec 2021 | $2.64 M(+105.1%) | $2.64 M(-6.7%) |
| Sept 2021 | - | $2.83 M(-6.1%) |
| June 2021 | - | $3.01 M(-5.7%) |
| Mar 2021 | - | $3.19 M(+148.2%) |
| Dec 2020 | $1.29 M | $1.29 M |
FAQ
- What is Inozyme Pharma annual long term debt?
- What is the all time high annual long term debt for Inozyme Pharma?
- What is Inozyme Pharma annual long term debt year-on-year change?
- What is Inozyme Pharma quarterly long term debt?
- What is the all time high quarterly long term debt for Inozyme Pharma?
- What is Inozyme Pharma quarterly long term debt year-on-year change?
What is Inozyme Pharma annual long term debt?
The current annual long term debt of INZY is $45.68 M
What is the all time high annual long term debt for Inozyme Pharma?
Inozyme Pharma all-time high annual long term debt is $45.68 M
What is Inozyme Pharma annual long term debt year-on-year change?
Over the past year, INZY annual long term debt has changed by +$39.72 M (+666.22%)
What is Inozyme Pharma quarterly long term debt?
The current quarterly long term debt of INZY is $42.23 M
What is the all time high quarterly long term debt for Inozyme Pharma?
Inozyme Pharma all-time high quarterly long term debt is $45.75 M
What is Inozyme Pharma quarterly long term debt year-on-year change?
Over the past year, INZY quarterly long term debt has changed by +$9.02 M (+27.14%)